A Rangoon pilot programme launched by Medicines Sans Frontieres in Burma is testing a new international access campaign using two new drugs — bedaquiline and delamanid — that are not widely available in countries like Burma that have a high tuberculosis (TB) burden.
Up to US$4.7 million of government funds have been poured into treatment for tuberculosis patients last year, according to the Deputy Health Minister.
Medical officials say supplies of vital tuberculosis medication will run out by October.
85,000 HIV sufferers to go without life-saving treatment, as donor govts backtrack on funding pledges
Apr 3, 2009 (DVB), A Burmese doctor has said that the country's leaders are ignoring the threat posed by HIV/AIDS in the hope that it will go away of its[…]
Dec 30, 2008 (DVB), Political prisoner and former school teacher Htay Lwin Oo died of tuberculosis on 28 December in Ohbo jail in Mandalay division, where he was serving a[…]
